IBRX vs BBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

IBRX

42.3
AI Score
VS
IBRX Wins

BBIO

32.9
AI Score

Investment Advisor Scores

IBRX

42score
Recommendation
HOLD

BBIO

33score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric IBRX BBIO Winner
Forward P/E 70.922 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 52.3% 192.6% BBIO
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 42.3/100 32.9/100 IBRX
Profit Margin 0.0% -59.8% IBRX
Beta 1.00 1.00 Tie
AI Recommendation HOLD EXTENDED Tie

Relative Price Performance (Last 90 Days)

IBRX 1M: -37.0% · 3M: -17.6% BBIO 1M: +22.5% · 3M: -0.4%

Current Technical Phase

IBRX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 34

RSI (14): 33.7 · Price: $6.24

BBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 70

RSI (14): 69.6 · Price: $79.58

Fundamentals Snapshot

Metric IBRX BBIO
Market Cap — —
Forward P/E -91.0 -291.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.5% 1.9%
Gross Margin 1.0% 0.9%
Operating Margin -1.6% 0.0%
EPS -1.06 -3.03
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, IBRX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.